Document Type : Systematic Review and Meta-analysis
Authors
1
Department of Dentistry, Lakhimpur Medical College and Hospital, North Lakhimpur, Assam, India.
2
Department of Dentistry, Jorhat Medical College and Hospital, Jorhat, Assam, India.
3
Department of Dentistry, Fakharuddin Ali Ahmed Medical College & Hospital, Barpeta, Assam, India.
4
Department of Prosthodontics, Government Dental College, Dibrugarh, Assam, India.
Abstract
Background: Aminolevulinic acid (ALA) mediated photodynamic therapy (PDT) is considered as an effective treatment option for oral premalignant lesions. ALA is a Food and Drug Administration (FDA) approved second-generation photosensitizer (PS) used both orally as well as topically. Objective: This systematic review aims to evaluate the efficacy of ALA-PDT for the treatment of oral premalignant lesions. Methods: The focused question was, “Is ALA-PDT effective in the treatment of oral premalignant lesions?”A literature search was made in PubMed/Medline and GoogleScholar using different combinations of the following keywords: photodynamic therapy, oral premalignant lesions, oral leukoplakia (OL), erythroplakia, oral erythroleukoplakia (OEL), oral verrucous hyperplasia (OVH); and oral lichen planus (OLP). Review articles, preclinical studies, case-reports, commentaries, letters to the Editor, unpublished articles, studies on photodynamic therapy used in areas other than the oral cavityand, articles published in languages other than English were excluded. The relevant information was summarized. Results: There were initially 64 results for the above parameters; 47 studies were excluded, leaving 17 studies for analysis. Characteristics of the included studies, PS, and PDT protocol were summarized. Conclusion: The outcome of the included studies suggested that ALA-PDT is an effective, easy to perform technique, well tolerated treatment with encouraging achievements in the treatment of oral premalignant lesions. No systemic side effects and skin photosensitivity were reported with topical ALA even within initial 48 hours after PDT, and patients were not required to avoid exposure to light following treatment. The clinical outcome of the ALA-PDT application, as reported in the studies, was also very promising, with either diminution in the size of the lesion or complete remission or improvement in signs and symptoms as well as reduced recurrence.
Keywords
Main Subjects
)